An updated COVID-19 vaccine is expected in September, but new variants like BA.2.86 are already spreading in the U.S.
that weren’t around even three months ago, remind us that SARS-CoV-2 is still a health threat for the coming fall and winter.
Based on the June recommendation, vaccine makers have been manufacturing updated vaccines that target XBB, in order to ensure enough doses are ready by the fall and winter season. How well do these vaccines work against the newer variants?that its XBB-based vaccine can neutralize the newer EG.5 and FL.1.5.1 variants as well as XBB. The results were based on early findings from a study the company conducted to test its vaccine in a small group of people.
Belgique Dernières Nouvelles, Belgique Actualités
Similar News:Vous pouvez également lire des articles d'actualité similaires à celui-ci que nous avons collectés auprès d'autres sources d'information.
Researchers on the cusp of a new vaccine modality breakthroughProfessor Bernd Rehm and Dr. Shuxiong Chen from the Griffith Institute for Drug Discovery (GRIDD) and Griffith's Center for Cell Factories and Biopolymers have succeeded in developing a new vaccine modality that is a stable particulate vaccine.
Lire la suite »
Researchers find vaccine may reduce severity of long-haul COVID symptomsGetting a COVID-19 vaccine may not only reduce a person's risk of getting long-haul COVID, but also could mean fewer symptoms for people who develop the condition.
Lire la suite »
Novavax's protein-based COVID vaccine induces broad functional immune response against XBB subvariants, data showsNovavax, Inc., a global company advancing protein-based vaccines with its novel Matrix-M™ adjuvant, today announced that its updated protein-based XBB COVID vaccine candidate induced neutralizing antibody responses to the EG.5.1 and XBB.1.16.6 subvariants in small animal and non-human primate studies.
Lire la suite »
US warns new spreading Covid variant could be most infectious yetOfficials have confirmed the presence of BA.2.86, a highly mutated form of Covid-19, in wastewater within the United States.
Lire la suite »
Griffith on the brink of technological breakthrough in vaccine developmentGriffith University researchers are on the brink of a technological breakthrough in vaccine development with a possible new vaccine modality.
Lire la suite »